Afton Scientific is making headlines with its substantial investment of over $200 million to expand its biopharmaceutical manufacturing facility in Albemarle County, Virginia. This significant expansion not only highlights the company's commitment to growth but also underscores the robust
PCI Pharma Services has made a monumental $365 million investment to enhance its capabilities in the assembly and packaging of sophisticated drug-device combination products, particularly those involving injectable formats. This global Contract Development and Manufacturing Organization (CDMO) aims
The long-term commercial supply agreement between Lonza and Vertex Pharmaceuticals marks a pivotal moment in the field of gene therapy, promising significant advancements for patients suffering from sickle cell disease (SCD) and beta-thalassemia. This collaboration focuses on the production of
KBI Biopharma, a prominent contract development and manufacturing organization (CDMO), encountered a critical issue during a GMP (Good Manufacturing Practice) production run. An unexpected pink discoloration appeared in the cell culture media, a crucial component for biologic drug production. The
Ireland has long established itself as a significant player in the global biopharmaceutical industry, boasting a thriving ecosystem supported by robust regulatory and governmental frameworks. With the recent appointment of Shane Ryan as the new president of the Irish Pharmaceutical Healthcare
Theratechnologies, a Quebec-based biopharmaceutical company, is currently navigating challenging waters as it faces potential disruptions in the supply of its crucial HIV medication, Egrifta SV. This drug is widely used to reduce excess abdominal fat in HIV patients suffering from lipodystrophy.
